Send to

Choose Destination
Ulus Travma Acil Cerrahi Derg. 2019 Mar;25(2):142-146. doi: 10.14744/tjtes.2019.04838.

Surgical treatment of post-transplant encapsulating peritoneal sclerosis: A single-center experience.

Author information

Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul-Turkey.



Encapsulating peritoneal sclerosis (EPS) related to peritoneal dialysis (PD) has a vague etiology and high mortality. In this study, our aim was to determine treatment options for EPS cases.


A total of 169 patients underwent kidney transplantation from January 2008 to January 2018 and 119 patients from a cadaveric and 50 patients from a living donor. Twenty-one patients were undergoing PD before the transplantation. The mean PD time was 6.9 (IQR 3-14) years. Four patients received surgical treatment for EPS that occurred after the transplant. After the surgical treatment, 2 patients died because of sepsis. Two patients were discharged without complications, but 1 had late-term EPS recurrence.


EPS is a rare but serious complication of long-term PD. It has a high mortality and morbidity rate. Long-term PD is the most significant factor for triggering EPS. Nutritional support and surgical intervention is the next step if medical treatment fails. Resistant cases should be treated surgically without much delay before the condition deteriorates.


It can be especially devastating for patients with a long-term PD history to have EPS after a successful transplant. Because EPS is a challenging condition, its management should be done in experienced clinics to decrease its mortality and morbidity rates.

Free full text

Supplemental Content

Full text links

Icon for LookUs Bilisim
Loading ...
Support Center